The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Adenocarcinoma, Bronchiolo-Alveolar

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Adenocarcinoma, Bronchiolo-Alveolar


High impact information on Adenocarcinoma, Bronchiolo-Alveolar


Chemical compound and disease context of Adenocarcinoma, Bronchiolo-Alveolar


Biological context of Adenocarcinoma, Bronchiolo-Alveolar


Anatomical context of Adenocarcinoma, Bronchiolo-Alveolar


Gene context of Adenocarcinoma, Bronchiolo-Alveolar


Analytical, diagnostic and therapeutic context of Adenocarcinoma, Bronchiolo-Alveolar


  1. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin. Tsuta, K., Ishii, G., Nitadori, J., Murata, Y., Kodama, T., Nagai, K., Ochiai, A. J. Pathol. (2006) [Pubmed]
  2. Coexpression of actin-related protein 2 and Wiskott-Aldrich syndrome family verproline-homologous protein 2 in adenocarcinoma of the lung. Semba, S., Iwaya, K., Matsubayashi, J., Serizawa, H., Kataba, H., Hirano, T., Kato, H., Matsuoka, T., Mukai, K. Clin. Cancer Res. (2006) [Pubmed]
  3. Survivin expression in atypical adenomatous hyperplasia of the lung. Nakanishi, K., Kawai, T., Kumaki, F., Hiroi, S., Mukai, M., Ikeda, E. Am. J. Clin. Pathol. (2003) [Pubmed]
  4. Acute effects of 4-ipomeanol on experimental lung tumors with bronchiolar or alveolar cell features in Syrian hamsters or C3H/HeNCr mice. Rehm, S., Devor, D.E. J. Cancer Res. Clin. Oncol. (1993) [Pubmed]
  5. Gefitinib inhibits MUC5AC synthesis in mucin-secreting non-small cell lung cancer cells. Kitazaki, T., Soda, H., Doi, S., Nakano, H., Nakamura, Y., Kohno, S. Lung Cancer (2005) [Pubmed]
  6. Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group Study. Hirsch, F.R., Varella-Garcia, M., McCoy, J., West, H., Xavier, A.C., Gumerlock, P., Bunn, P.A., Franklin, W.A., Crowley, J., Gandara, D.R. J. Clin. Oncol. (2005) [Pubmed]
  7. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. Hirsch, F.R., Varella-Garcia, M., Bunn, P.A., Di Maria, M.V., Veve, R., Bremmes, R.M., Barón, A.E., Zeng, C., Franklin, W.A. J. Clin. Oncol. (2003) [Pubmed]
  8. CD208/dendritic cell-lysosomal associated membrane protein is a marker of normal and transformed type II pneumocytes. Salaun, B., de Saint-Vis, B., Pacheco, N., Pacheco, Y., Riesler, A., Isaac, S., Leroux, C., Clair-Moninot, V., Pin, J.J., Griffith, J., Treilleux, I., Goddard, S., Davoust, J., Kleijmeer, M., Lebecque, S. Am. J. Pathol. (2004) [Pubmed]
  9. Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Bellocq, A., Antoine, M., Flahault, A., Philippe, C., Crestani, B., Bernaudin, J.F., Mayaud, C., Milleron, B., Baud, L., Cadranel, J. Am. J. Pathol. (1998) [Pubmed]
  10. Production of gastrin-releasing peptide by a non-small cell lung carcinoma cell line adapted to serum-free and growth factor-free conditions. Siegfried, J.M., Han, Y.H., DeMichele, M.A., Hunt, J.D., Gaither, A.L., Cuttitta, F. J. Biol. Chem. (1994) [Pubmed]
  11. Binding of adenovirus capsid to dipalmitoyl phosphatidylcholine provides a novel pathway for virus entry. Balakireva, L., Schoehn, G., Thouvenin, E., Chroboczek, J. J. Virol. (2003) [Pubmed]
  12. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Maeno, T., Tanaka, T., Sando, Y., Suga, T., Maeno, Y., Nakagawa, J., Hosono, T., Sato, M., Akiyama, H., Kishi, S., Nagai, R., Kurabayashi, M. Am. J. Respir. Cell Mol. Biol. (2002) [Pubmed]
  13. Epidermal growth factor receptor domain II, IV, and kinase domain mutations in human solid tumors. Sihto, H., Puputti, M., Pulli, L., Tynninen, O., Koskinen, W., Aaltonen, L.M., Tanner, M., Böhling, T., Visakorpi, T., Bützow, R., Knuuttila, A., Nupponen, N.N., Joensuu, H. J. Mol. Med. (2005) [Pubmed]
  14. Inhibition of beta-oxidative respiration is a therapeutic window associated with the cancer chemo-preventive activity of PPARgamma agonists. Andela, V.B., Altuwaijri, S., Wood, J., Rosier, R.N. FEBS Lett. (2005) [Pubmed]
  15. Development of pulmonary bronchiolo-alveolar adenocarcinomas in transgenic mice overexpressing murine c-myc and epidermal growth factor in alveolar type II pneumocytes. Ehrhardt, A., Bartels, T., Geick, A., Klocke, R., Paul, D., Halter, R. Br. J. Cancer (2001) [Pubmed]
  16. Expression of the TSLC1 adhesion molecule in pulmonary epithelium and its down-regulation in pulmonary adenocarcinoma other than bronchioloalveolar carcinoma. Ito, A., Okada, M., Uchino, K., Wakayama, T., Koma, Y., Iseki, S., Tsubota, N., Okita, Y., Kitamura, Y. Lab. Invest. (2003) [Pubmed]
  17. Estradiol and nicotine exposure enhances A549 bronchioloalveolar carcinoma xenograft growth in mice through the stimulation of angiogenesis. Jarzynka, M.J., Guo, P., Bar-Joseph, I., Hu, B., Cheng, S.Y. Int. J. Oncol. (2006) [Pubmed]
  18. Oxidative metabolism of rat blood in the course of alveolar hepatic carcinoma PC-1 growth. Smolyakova, R.M., Prokhorova, V.I., Zhavrid, E.A., Mashevsky, A.A., Istomin, Y.P. Eksp. Onkol. (2004) [Pubmed]
  19. Molecular cloning and characterization of canine pre-B-cell colony-enhancing factor. McGlothlin, J.R., Gao, L., Lavoie, T., Simon, B.A., Easley, R.B., Ma, S.F., Rumala, B.B., Garcia, J.G., Ye, S.Q. Biochem. Genet. (2005) [Pubmed]
  20. Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioalveolar cell carcinoma. Albertine, K.H., Steiner, R.M., Radack, D.M., Golding, D.M., Peterson, D., Cohn, H.E., Farber, J.L. Chest (1998) [Pubmed]
  21. Chymase-positive mast cells in small sized adenocarcinoma of the lung. Nagata, M., Shijubo, N., Walls, A.F., Ichimiya, S., Abe, S., Sato, N. Virchows Arch. (2003) [Pubmed]
  22. A three-dimensional analysis of blood vessels in bronchioloalveolar carcinoma. Uehara, T., Honda, T., Sano, K., Hachiya, T., Ota, H. Lung (2004) [Pubmed]
  23. Dietary lipids modulate eicosanoid release and apoptosis of cells of a murine lung alveolar carcinoma. Pasqualini, M.E., Berra, M.A., Calderón, R.O., Cremonezzi, D.C., Giraudo, C., Eynard, A.R. Prostaglandins Leukot. Essent. Fatty Acids (2005) [Pubmed]
  24. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations. Marchetti, A., Pellegrini, S., Bertacca, G., Buttitta, F., Gaeta, P., Carnicelli, V., Nardini, V., Griseri, P., Chella, A., Angeletti, C.A., Bevilacqua, G. J. Pathol. (1998) [Pubmed]
  25. Expression of mRNAs for telomeric repeat binding factor (TRF)-1 and TRF2 in atypical adenomatous hyperplasia and adenocarcinoma of the lung. Nakanishi, K., Kawai, T., Kumaki, F., Hiroi, S., Mukai, M., Ikeda, E., Koering, C.E., Gilson, E. Clin. Cancer Res. (2003) [Pubmed]
  26. Mucinous bronchioloalveolar carcinomas display a specific pattern of mucin gene expression among primary lung adenocarcinomas. Copin, M.C., Buisine, M.P., Leteurtre, E., Marquette, C.H., Porte, H., Aubert, J.P., Gosselin, B., Porchet, N. Hum. Pathol. (2001) [Pubmed]
  27. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma. McDonald, J.W., Pilgram, T.K. Histopathology (1999) [Pubmed]
  28. Lack of reverse transformation after treatment of A 549 human alveolar carcinoma cells with thioproline. Rigaud, O., Coppey, J., Magdelenat, H. Cancer Lett. (1983) [Pubmed]
  29. A genomic response of H-358 bronchiolar carcinoma cells to MK 886, an inhibitor of 5-lipoxygenase, assessed with a cDNA array. Anderson, K.M., Alrefai, W.A., Bonomi, P.A., Anderson, C.A., Dudeja, P., Harris, J.E. Anticancer Res. (2000) [Pubmed]
  30. F-18 fluorodeoxyglucose positron emission tomography in pulmonary cryptococcoma. Hsu, C.H., Lee, C.M., Wang, F.C., Lin, Y.H. Clinical nuclear medicine. (2003) [Pubmed]
WikiGenes - Universities